Why is Astec Lifescienc falling/rising?

As of 10-Jul, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at 897.45, which reflects a decrease of 10.25 or 1.13%. The stock has shown a negative performance today, aligning with a significant drop in delivery volume, which fell by 58.63% against the 5-day average. Over the past week, the stock has decreased by 6.32%, while it has seen a modest increase of 11.15% over the past month. However, the company has faced consistent underperformance, with a staggering decline of 33.08% over the past year, and a negative trend in operating profits, which has contributed to its weak long-term fundamental strength. Despite a recent increase in promoter confidence, with a 4.12% rise in their stake, the overall financial health of the company remains concerning due to negative results over the last four quarters.
In the broader market context, the stock's performance has been notably poor compared to the benchmark, as it has underperformed the Sensex significantly over various periods, including a 56.80% decline over the last three years, while the benchmark has gained 52.69%. This stark contrast highlights the challenges faced by Astec Lifesciences Ltd, particularly in light of its negative EBITDA and high debt levels, which further exacerbate investor concerns. While the stock may be liquid enough for trading, the overall sentiment remains bearish due to its inability to generate positive returns and the ongoing decline in profitability.